Immuno AG. v. Moor-Jankowski

549 N.E.2d 129, 74 N.Y.2d 548, 17 Media L. Rep. (BNA) 1161, 549 N.Y.S.2d 938, 1989 N.Y. LEXIS 4376
CourtNew York Court of Appeals
DecidedDecember 14, 1989
StatusPublished
Cited by20 cases

This text of 549 N.E.2d 129 (Immuno AG. v. Moor-Jankowski) is published on Counsel Stack Legal Research, covering New York Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Immuno AG. v. Moor-Jankowski, 549 N.E.2d 129, 74 N.Y.2d 548, 17 Media L. Rep. (BNA) 1161, 549 N.Y.S.2d 938, 1989 N.Y. LEXIS 4376 (N.Y. 1989).

Opinion

OPINION OF THE COURT

Kaye, J.

This appeal concerns application of the "settled rule that expressions of an opinion 'false or not, libelous or not, are constitutionally protected and may not be the subject of private damage actions’ ”. (Steinhilber v Alphonse, 68 NY2d 283, 286.) Settled though the rule may be, the line separating protected expressions of opinion from actionable assertions of fact has proved elusive. In this case, the primary — and vehemently contested — dispute between the parties concerns the proper category for a letter to the editor of a scientific journal.

I.

This libel action arises out of a letter to the editor published in the Journal of Medical Primatology in December 1983. The letter was written by Dr. Shirley McGreal, chairwoman of the International Primate Protection League (IPPL), an organization known for its vigorous advocacy on behalf of primates, particularly those used for biomedical research. Defendant Dr. J. Moor-Jankowski, a professor of medical research at New York University School of Medicine and director of the Laboratory for Experimental Medicine and Surgery in Primates of the New York University Medical Center, is cofounder and editor of the Journal.

The subject of McGreal’s letter (reprinted at 145 AD2d, at 118-120) was a plan by plaintiff, Immuno AG. — a multinational corporation based in Austria that manufactures biologic products derived from blood plasma — to establish a facility in Sierra Leone for hepatitis research using chimpanzees. McGreal’s letter was critical of Immuno’s proposal on a number of grounds: (1) that the motivation for the plan was to avoid international policies or legal restrictions on the importation of chimpanzees, an endangered species; (2) that it could decimate the wild chimpanzee population, as capture of chimpan[554]*554zees generally involved killing their mothers, and efforts at returning experimental animals to the wild (as plaintiff proposed) were of questionable success; and (3) that returning the animals to the wild risked spreading hepatitis to the rest of the chimpanzee population. McGreal stated that the current population of captive chimpanzees should be adequate to supply any legitimate requirements.

The letter was prefaced by an editorial note written by defendant that set out its background. Identifying McGreal as chairwoman of IPPL, the note stated that the Journal had received the initial version of the letter in January 1983 and had submitted it to plaintiff for comment or reply. Plaintiff had acknowledged receipt of the letter in February, offering no comment but that it was referring the matter to its New York lawyers. Thereafter, plaintiff’s lawyers wrote that Mc-Greal’s statements were inaccurate, unfair and reckless, and requested the documents upon which the accusations were based, threatening legal action if the letter were printed before plaintiff had a meaningful opportunity to reply. The editorial note went on to state that the editors had advised plaintiff’s attorneys that they should obtain the documentation directly from McGreal, and extended the period for plaintiff’s reply by two months. The letter was published nearly a year after its receipt, after articles had appeared in the Austrian press apparently confirming much of what Mc-Greal had written, and after receiving no further word from plaintiff or its lawyers.

In addition to the McGreal letter that is the focus of contention, plaintiff complains that it was defamed by comments made by defendant quoted in an article entitled "Loophole May Allow Trade in African Chimps” that appeared in the New Scientist magazine shortly before McGreal’s letter was published. Defendant is quoted as saying that the supply of captive chimpanzees was sufficient for research, describing defendant’s attempts to circumvent controls on endangered species as "scientific imperialism,” and warning that they will "backfire on people like me involved in the bona fide use of chimpanzees and other primate animals” for research.

In December 1984, plaintiff commenced this lawsuit against Moor-Jankowski and seven other defendants, including Mc-Greal and the publishers and distributors of the New Scientist and the Journal of Medical Primatology. All the defendants save Moor-Jankowski settled with plaintiff for what the mo[555]*555tion court described as "substantial sums,” and the complaint was dismissed as to them. After extensive discovery, defendant moved for summary judgment. Supreme Court granted the motion to the extent of dismissing a claim for prima facie tort. It denied the motion as to the defamation claims, ruling that the statements at issue were statements of fact and, regardless of whether plaintiff was a public figure, there were triable issues of fact concerning whether defendant acted with actual malice in making or publishing the statements.

On defendant’s appeal, the Appellate Division unanimously reversed, granted defendant’s motion and dismissed the complaint. The court held that all of the comments attributed to defendant in the New Scientist article were expressions of opinion that could not, as a matter of law, support an action for defamation. As to the McGreal letter, the Appellate Division held that for the most part it too was a constitutionally protected expression of opinion. To the extent that it contained statements of a factual nature, the Appellate Division examined each statement meticulously, and concluded from the voluminous record not only that plaintiff had failed to adduce evidence of falsity but also that all such factual assertions were demonstrably true.

With respect to the comments attributed to defendant in the New Scientist article, we now affirm the Appellate Division order for the reasons stated by that court (145 AD2d 114, 143). With respect to the McGreal letter, we also affirm the Appellate Division order, but on a somewhat different analysis.

II.

However difficult the philosophical or practical problem of disentangling assertions of fact from statements that do not imply or assert factual matters ("opinion” in the parlance of defamation law analysis), it is settled that pure opinion— however misguided or vituperative — is entitled to the absolute protection of the State and Federal constitutional free speech guarantees (see, Steinhilber v Alphonse, 68 NY2d, at 289, supra; Ollman v Evans, 750 F2d 970, 974-975, n 6 [DC Cir] [en banc], cert denied 471 US 1127).

This distinction between fact and opinion, which grew out of the common-law doctrine of fair comment, was elevated to constitutional status, in the interpretation of State and Federal courts, by the Supreme Court’s widely cited dictum in [556]*556Gertz v Robert Welch, Inc. (418 US 323, 339-340), that "[u]nder the First Amendment there is no such thing as a false idea. However pernicious an opinion may seem, we depend for its correction not on the conscience of judges and juries but on the competition of other ideas. Neither the intentional lie nor the careless error materially advances society’s interest in 'uninhibited, robust, and wide-open debate on the public issues.’ ” (Quoting New York Times Co. v Sullivan, 376 US 254, 270.)

It has been suggested that one reason for the distinction between fact and opinion is that statements of fact have greater potential for influence and hence are likelier to damage reputation than mere expressions of opinion, which are more readily discounted by the reader or listener. (Note, Fair Comment,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carter-Clark v. Random House, Inc.
196 Misc. 2d 1011 (New York Supreme Court, 2003)
Alianza Dominicana, Inc. v. Luna
229 A.D.2d 328 (Appellate Division of the Supreme Court of New York, 1996)
Levin v. McPhee
917 F. Supp. 230 (S.D. New York, 1996)
Church of Scientology International v. Time Warner, Inc.
903 F. Supp. 637 (S.D. New York, 1995)
Rappaport v. VV Publishing Corp.
163 Misc. 2d 1 (New York Supreme Court, 1994)
West v. Thomson Newspapers
872 P.2d 999 (Utah Supreme Court, 1994)
Love v. William Morrow & Co.
193 A.D.2d 586 (Appellate Division of the Supreme Court of New York, 1993)
Gross v. New York Times Co.
180 A.D.2d 308 (Appellate Division of the Supreme Court of New York, 1992)
Abernathy & Closther v. Buffalo Broadcasting Co.
176 A.D.2d 300 (Appellate Division of the Supreme Court of New York, 1991)
600 West 115th Street Corp. v. Von Gutfeld
169 A.D.2d 56 (Appellate Division of the Supreme Court of New York, 1991)
McNally v. Yarnall
764 F. Supp. 838 (S.D. New York, 1991)
Immuno AG. v. Moor-Jankowski
567 N.E.2d 1270 (New York Court of Appeals, 1991)
Lesyk v. Putnam County News & Recorder
164 A.D.2d 881 (Appellate Division of the Supreme Court of New York, 1990)
Don King Productions, Inc. v. Douglas
742 F. Supp. 778 (S.D. New York, 1990)
Ware v. Valley Stream High School District
550 N.E.2d 420 (New York Court of Appeals, 1989)
Weiner v. Doubleday & Co.
549 N.E.2d 453 (New York Court of Appeals, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
549 N.E.2d 129, 74 N.Y.2d 548, 17 Media L. Rep. (BNA) 1161, 549 N.Y.S.2d 938, 1989 N.Y. LEXIS 4376, Counsel Stack Legal Research, https://law.counselstack.com/opinion/immuno-ag-v-moor-jankowski-ny-1989.